Profound Medical (PROF) Competitors $5.98 -0.11 (-1.72%) As of 07/3/2025 03:19 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PROF vs. CBLL, BBNX, AVNS, EMBC, BVS, KIDS, RXST, BFLY, AXGN, and DCTHShould you be buying Profound Medical stock or one of its competitors? The main competitors of Profound Medical include CeriBell (CBLL), Beta Bionics (BBNX), Avanos Medical (AVNS), Embecta (EMBC), Bioventus (BVS), OrthoPediatrics (KIDS), RxSight (RXST), Butterfly Network (BFLY), AxoGen (AXGN), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. Profound Medical vs. Its Competitors CeriBell Beta Bionics Avanos Medical Embecta Bioventus OrthoPediatrics RxSight Butterfly Network AxoGen Delcath Systems Profound Medical (NASDAQ:PROF) and CeriBell (NASDAQ:CBLL) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings. Which has higher valuation & earnings, PROF or CBLL? Profound Medical has higher earnings, but lower revenue than CeriBell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProfound Medical$10.68M16.84-$27.82M-$1.22-4.91CeriBell$65.44M10.45-$40.46MN/AN/A Do insiders and institutionals have more ownership in PROF or CBLL? 47.9% of Profound Medical shares are held by institutional investors. 1.5% of Profound Medical shares are held by company insiders. Comparatively, 20.1% of CeriBell shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media refer more to PROF or CBLL? In the previous week, Profound Medical had 1 more articles in the media than CeriBell. MarketBeat recorded 1 mentions for Profound Medical and 0 mentions for CeriBell. Profound Medical's average media sentiment score of 0.75 beat CeriBell's score of 0.00 indicating that Profound Medical is being referred to more favorably in the media. Company Overall Sentiment Profound Medical Positive CeriBell Neutral Do analysts recommend PROF or CBLL? Profound Medical presently has a consensus target price of $11.50, suggesting a potential upside of 92.15%. CeriBell has a consensus target price of $32.14, suggesting a potential upside of 69.84%. Given Profound Medical's higher possible upside, research analysts clearly believe Profound Medical is more favorable than CeriBell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Profound Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00CeriBell 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is PROF or CBLL more profitable? CeriBell has a net margin of 0.00% compared to Profound Medical's net margin of -269.35%. CeriBell's return on equity of 0.00% beat Profound Medical's return on equity.Company Net Margins Return on Equity Return on Assets Profound Medical-269.35% -70.41% -57.22% CeriBell N/A N/A N/A SummaryProfound Medical and CeriBell tied by winning 6 of the 12 factors compared between the two stocks. Get Profound Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PROF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PROF vs. The Competition Export to ExcelMetricProfound MedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$179.85M$2.41B$5.49B$9.02BDividend YieldN/A1.77%5.38%4.10%P/E Ratio-4.918.9827.4720.28Price / Sales16.84669.86408.86121.46Price / CashN/A157.0736.6357.47Price / Book2.984.638.095.68Net Income-$27.82M$31.34M$3.17B$248.96M7 Day Performance-0.25%3.25%2.81%3.30%1 Month Performance8.42%6.80%3.67%5.20%1 Year Performance-30.89%1.89%35.41%21.37% Profound Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PROFProfound Medical2.7137 of 5 stars$5.99-1.7%$11.50+92.1%-30.9%$179.85M$10.68M-4.91150CBLLCeriBell2.121 of 5 stars$18.73-0.9%$32.14+71.6%N/A$683.10M$65.44M0.00N/ABBNXBeta BionicsN/A$14.56-3.4%$23.44+61.0%N/A$653.38M$65.12M0.00294AVNSAvanos Medical2.509 of 5 stars$12.25+0.3%N/A-36.4%$564.64M$689.20M-1.462,227EMBCEmbecta4.3543 of 5 stars$9.69+0.5%$19.33+99.5%-14.5%$563.39M$1.12B10.772,100BVSBioventus3.4386 of 5 stars$6.62-2.2%$14.33+116.5%+21.3%$543.79M$567.70M-10.851,200KIDSOrthoPediatrics4.2435 of 5 stars$21.48+0.5%$35.83+66.8%-25.0%$519M$204.73M-12.27200RXSTRxSight1.4207 of 5 stars$13.00+2.6%$37.90+191.5%-76.8%$514.87M$139.93M-19.40220Positive NewsBFLYButterfly Network2.5221 of 5 stars$2.00+1.8%$4.00+100.5%+103.2%$484.69M$82.06M-6.88460News CoverageAnalyst ForecastGap DownAXGNAxoGen2.7439 of 5 stars$10.85+3.3%$22.20+104.6%+42.6%$478.21M$187.34M-72.33450Positive NewsHigh Trading VolumeDCTHDelcath Systems3.631 of 5 stars$13.60+0.2%$24.00+76.5%+60.9%$472.59M$37.21M-27.2060 Related Companies and Tools Related Companies CBLL Competitors BBNX Competitors AVNS Competitors EMBC Competitors BVS Competitors KIDS Competitors RXST Competitors BFLY Competitors AXGN Competitors DCTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PROF) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PROF Stock Alerts